-
Product Insights
GP Wind Jangi Wind Farm
GP Wind Jangi Wind Farm is an Onshore Wind project located in Gujarat, India. The project is owned and developed by GP Wind (Jangi) Private Limited. The project came online in 2011. Empower your strategies with our GP Wind Jangi Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
GP Joule Euerwang Solar PV Park
GP Joule Euerwang Solar PV Park is a solar PV project located in Bavaria, Germany. The project is owned and developed by GP Joule GmbH. The project came online in 2017. Empower your strategies with our GP Joule Euerwang Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Sector Analysis
NewAutomotive Autonomous Driving Systems Market Trends, Sector Overview and Forecast to 2028
The size of the global autonomous driving systems market was 212.5 mn units in 2023, recording a substantial annual growth of 15.2%. During 2018–23, the sector posted a CAGR of 5.1%. Over the forecast period, the sector is expected to record a CAGR of 5.2% to reach 274.2 mn units by 2028. In 2023 adaptive cruise control (ACC) garnered a share of 14.0%, radar -–long range garnered a share of 16.3%, radar-short/medium garnered a share of 27.7%, and GPS/GNSS unit...
-
Company Insights
Innovation and Patenting activity of Plains GP Holdings LP Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Plains GP Holdings LP Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GP-2250 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GP-2250 in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GP-2250 in Pancreatic Cancer Drug Details:GP-2250 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GP-2250 in Metastatic Adenocarcinoma of The Pancreas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GP-2250 in Metastatic Adenocarcinoma of The Pancreas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GP-2250 in Metastatic Adenocarcinoma of The Pancreas Drug Details:GP-2250 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GP-01CR01 in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GP-01CR01 in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GP-01CR01 in Multiple Myeloma (Kahler Disease)Drug Details:GP01CR01 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denosumab Biosimilar in Bone Metastasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denosumab Biosimilar in Bone Metastasis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Denosumab Biosimilar in Bone Metastasis Drug Details: Denosumab (Jubbonti), is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denosumab Biosimilar in Post Menopausal Osteoporosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denosumab Biosimilar in Post Menopausal Osteoporosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Denosumab Biosimilar in Post Menopausal Osteoporosis Drug Details: denosumab biosimilar...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denosumab Biosimilar in Humoral Hypercalcemia of Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denosumab Biosimilar in Humoral Hypercalcemia of Malignancy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Denosumab Biosimilar in Humoral Hypercalcemia of Malignancy Drug Details:...